A cost–benefit analysis of the implementation and scale‐up of harm reduction interventions in the Australian Capital Territory

Key Points

• Cost-saving harm reduction interventions likely mitigate overdose risks effectively.
• Societal impacts of interventions suggest expanded harm reduction measures are beneficial.
• Modeling indicates increased drug circulation raises overdose risks, amplifying intervention needs.
• Studying the cost-effectiveness of drug interventions supports broader policy changes in Australia.

Abstract